Discovery of Chemical Scaffolds as Lysophosphatidic Acid Receptor 1 Antagonists: Virtual Screening, In Vitro Validation, and Molecular Dynamics Analysis
Main Authors: | Lan Phuong Nguyen, Rasel Ahmed Khan, Soomin Kang, Hobin Lee, Jong-Ik Hwang, Hong-Rae Kim |
---|---|
Format: | Article |
Language: | English |
Published: |
American Chemical Society
2023-10-01
|
Series: | ACS Omega |
Online Access: | https://doi.org/10.1021/acsomega.3c04798 |
Similar Items
-
Lysophosphatidic Acid Receptor Antagonists and Cancer: The Current Trends, Clinical Implications, and Trials
by: Yu-Hsuan Lin, et al.
Published: (2021-06-01) -
Lysophosphatidic Acid Inhibits Simvastatin-Induced Myocytoxicity by Activating LPA Receptor/PKC Pathway
by: Kyung-Jong Won, et al.
Published: (2020-03-01) -
In vitro pharmacological characterization of standard and new lysophosphatidic acid receptor antagonists using dynamic mass redistribution assay
by: C. Ruzza, et al.
Published: (2023-11-01) -
Discovery of novel A2AR antagonists through deep learning-based virtual screening
by: Miru Tang, et al.
Published: (2023-12-01) -
AM966, an Antagonist of Lysophosphatidic Acid Receptor 1, Increases Lung Microvascular Endothelial Permeability through Activation of Rho Signaling Pathway and Phosphorylation of VE-Cadherin
by: Junting Cai, et al.
Published: (2017-01-01)